A detailed history of Chatham Capital Group, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Chatham Capital Group, Inc. holds 29,344 shares of PFE stock, worth $870,343. This represents 0.14% of its overall portfolio holdings.

Number of Shares
29,344
Previous 31,594 7.12%
Holding current value
$870,343
Previous $876,000 6.28%
% of portfolio
0.14%
Previous 0.16%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$25.26 - $29.6 $56,835 - $66,600
-2,250 Reduced 7.12%
29,344 $821,000
Q1 2024

Apr 17, 2024

BUY
$25.89 - $29.73 $32,025 - $36,776
1,237 Added 4.07%
31,594 $876,000
Q4 2023

Jan 19, 2024

SELL
$26.13 - $33.94 $33,263 - $43,205
-1,273 Reduced 4.02%
30,357 $873,000
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $5,166 - $6,039
161 Added 0.51%
31,630 $1.05 Million
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $902 - $1,044
25 Added 0.08%
31,469 $1.15 Million
Q1 2023

Apr 21, 2023

SELL
$39.39 - $51.28 $7,878 - $10,256
-200 Reduced 0.63%
31,444 $1.28 Million
Q4 2022

Jan 31, 2023

SELL
$41.75 - $54.5 $16,658 - $21,745
-399 Reduced 1.25%
31,644 $1.62 Million
Q3 2022

Oct 28, 2022

SELL
$43.76 - $53.42 $2,494 - $3,044
-57 Reduced 0.18%
32,043 $1.4 Million
Q2 2022

Aug 02, 2022

SELL
$46.53 - $55.17 $15,401 - $18,261
-331 Reduced 1.02%
32,100 $1.68 Million
Q1 2022

Apr 21, 2022

SELL
$45.75 - $56.69 $84,591 - $104,819
-1,849 Reduced 5.39%
32,431 $1.68 Million
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $21,073 - $31,237
510 Added 1.51%
34,280 $2.02 Million
Q3 2021

Oct 13, 2021

BUY
$39.25 - $50.42 $45,765 - $58,789
1,166 Added 3.58%
33,770 $1.45 Million
Q2 2021

Jul 28, 2021

BUY
$35.91 - $40.68 $136,062 - $154,136
3,789 Added 13.15%
32,604 $1.28 Million
Q1 2021

Apr 29, 2021

BUY
$33.49 - $37.77 $12,759 - $14,390
381 Added 1.34%
28,815 $1.04 Million
Q4 2020

Jan 27, 2021

BUY
$33.47 - $42.56 $26,474 - $33,664
791 Added 2.86%
28,434 $1.05 Million
Q3 2020

Oct 22, 2020

SELL
$31.75 - $37.25 $63,468 - $74,462
-1,999 Reduced 6.74%
27,643 $1.02 Million
Q2 2020

Jul 20, 2020

BUY
$30.12 - $36.54 $3,012 - $3,654
100 Added 0.34%
29,642 $969,000
Q1 2020

May 01, 2020

SELL
$27.03 - $38.62 $20,083 - $28,694
-743 Reduced 2.45%
29,542 $964,000
Q4 2019

Jan 31, 2020

SELL
$32.92 - $37.36 $23,702 - $26,899
-720 Reduced 2.32%
30,285 $1.19 Million
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $12,508 - $16,220
-385 Reduced 1.23%
31,005 $1.11 Million
Q1 2019

May 09, 2019

BUY
$37.5 - $41.2 $11,250 - $12,360
300 Added 0.96%
31,390 $1.33 Million
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $9,348 - $10,657
243 Added 0.79%
31,090 $1.36 Million
Q3 2018

Oct 30, 2018

SELL
$34.47 - $41.81 $11,650 - $14,131
-338 Reduced 1.08%
30,847 $1.36 Million
Q2 2018

Jul 30, 2018

BUY
$32.98 - $35.16 $32,584 - $34,738
988 Added 3.27%
31,185 $1.13 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $284,094 - $329,589
-8,903 Reduced 22.77%
30,197 $1.07 Million
Q3 2017

Nov 08, 2017

SELL
$31.0 - $34.15 $78,988 - $87,014
-2,548 Reduced 6.12%
39,100 $1.4 Million
Q2 2017

Aug 09, 2017

BUY
N/A
41,648
41,648 $1.4 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Chatham Capital Group, Inc. Portfolio

Follow Chatham Capital Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chatham Capital Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chatham Capital Group, Inc. with notifications on news.